Hypermarcas (OTCMKTS:HYPMY) Stock Price Up 9.9% – Still a Buy?

Hypermarcas (OTCMKTS:HYPMY) rose 9.9% during mid-day trading on Wednesday . The stock traded as high as $4.54 and last traded at $4.54. Approximately 760 shares were traded during trading, a decline of 99% from the average daily volume of 51,472 shares. The stock had previously closed at $4.13.

Hypermarcas Stock Performance

The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61. The stock has a fifty day moving average price of $4.52 and a 200 day moving average price of $4.51. The firm has a market cap of $2.53 billion, a price-to-earnings ratio of 17.39 and a beta of 0.73.

Hypermarcas (OTCMKTS:HYPMY) last issued its quarterly earnings results on Wednesday, November 12th. The company reported $0.13 earnings per share (EPS) for the quarter. The firm had revenue of $408.83 million for the quarter. Hypermarcas had a return on equity of 6.89% and a net margin of 12.03%.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.